Healthequity (HQY) EBIT (2013 - 2026)

Healthequity has reported EBIT for 14 years, with the latest figure at $98.7 million in Q3 2026.

• On a quarterly basis, EBIT rose 10.13% year-over-year to $98.7 million in Q3 2026; TTM through Jul 2026 was $351.4 million, a 49.88% increase from a year earlier, with the FY2026 full-year figure at $322.5 million, up 98.64% from the prior year.
• EBIT was $98.7 million for Q3 2026 at Healthequity, down from $103.0 million in the prior quarter.
• The five-year high for EBIT was $103.0 million in Q2 2026, with the low at -$27.2 million in Q1 2022.
• Average EBIT over 5 years is $41.4 million, with a median of $38.9 million recorded in 2024.
• The largest YoY upside for EBIT was 1614.21% in 2022 against a maximum downside of 1617.08% in 2022.
• Over 5 years, EBIT stood at $5.5 million in 2022, then soared by 457.4% to $30.9 million in 2023, then tumbled by 36.47% to $19.6 million in 2024, then jumped by 300.99% to $78.7 million in 2025, then gained by 25.41% to $98.7 million in 2026.
• The last three EBIT figures came in at $98.7 million (Q3 2026), $103.0 million (Q2 2026), and $71.1 million (Q1 2026), per Business Quant data.